Detalles de la búsqueda
1.
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
Future Oncol
; 19(22): 1523-1534, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199326
2.
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer.
Ther Adv Med Oncol
; 16: 17588359231217959, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38249330
3.
Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer: case report and review of the literature.
Ther Adv Med Oncol
; 15: 17588359231193722, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667781
Resultados
1 -
3
de 3
1
Próxima >
>>